Oxazolidinonantibiotika

European patent · EP2915813 · Deleted

Register entry

Publication number
EP2915813
Application number
EP15154086
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 11, 2008
Published
Sep 9, 2015
Granted
Feb 1, 2017
Deleted
Apr 30, 2019
Reason
Annual fee unpaid
IPC classes
C07D 471/04 (2006.01)
A61K 31/435 (2006.01)
A61P 31/00 (2006.01)
Priority
WO PCT/IB2007/051290 11.04.2007
WO PCT/IB2007/054587 12.11.2007
WO PCT/IB2007/054768 23.11.2007
Divided from
EP08737800
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 20, 2019

    Deleted, fee unpaid

    Published in Swissreg on 20.11.2019

  2. Sep 14, 2017

    Transferred

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  3. Feb 1, 2017

    Granted

    Published in Swissreg on 01.02.2017

Parties

Holder

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Inventor

Bur, Daniel

4123 Allschwil

Hubschwerlen, Christian

68480 Durmenach, FR

Rueedi, Georg

4123 Allschwil

Surivet, Jean-Philippe

4123 Allschwil

Zumbrunn, Cornelia

4123 Allschwil

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.